Abstract
Inspiratory Rint better detects BHR than expiratory Rint and might better match PD20PtcO2 changes http://ow.ly/TrMvB
To the Editor:
In young children unable to perform reliable and reproducible spirometry, non-cooperative lung function techniques are necessary to measure bronchial hyperreactivity (BHR) during bronchial challenge [1]. Measuring the decrease in transcutaneous partial pressure of oxygen (PtcO2) is a robust technique that detects increased ventilation–perfusion mismatch during bronchial challenge [2] in preschool and school-aged children [3–5], and a 20% decrease in PtcO2 correlates to a 20% forced expiratory volume in 1 s (FEV1) decrease in children aged 6–14 years [3] and in adults (with correlation to arterial oxygen tension) [6]. When neither spirometry nor PtcO2 is available, other BHR outcomes can be measured such as wheezing that appears for mean±sd decreases of −44.7±14.5% in FEV1 and −6.3±2.7% in transcutaneous saturation of oxygen (SpO2) [7]. Respiratory resistances are easy to measure [8–10] but the relevant threshold for BHR is not yet defined and an at least 35% increase variably correlates with PtcO2 changes [8, 11]. First, we aimed to better study two alternative outcomes (i.e. interrupter resistance (Rint) and SpO2) and challenge the current recommendations [1] of measuring resistance during inspiration (as opposed to measuring during expiration for reversibility testing [12]), because the physiological expiratory glottis closure can be enhanced during bronchial challenge-induced bronchoconstriction and specific extrathoracic airway reactivity to bronchoconstrictor agents can occur. Second, we wished to evaluate the proposed thresholds for Rint and SpO2 (+35% and −5% baseline, respectively), as only a 3% decrease is considered to be significant in sleep studies and a mean±sd SpO2 decrease of −5.2±3.1% corresponds to a much larger than 20% decrease in FEV1 in 5–8-year-old asthmatic children (−33.3±7.4% decrease in FEV1) [13].
Between June 2013 and September 2014, we prospectively and consecutively included 28 children unable to correctly perform a spirometry who were referred to our lung function laboratory for a methacholine challenge. Children had to be free of treatment and acute respiratory symptoms for 3 weeks. Chest auscultation had to be normal.
At each step of the bronchial challenge, inspiratory and expiratory series of at least five correct interruptions (Rintinsp and Rintexp, respectively) were performed in random order (but always in the same order with each specific child) using a MicroRint device (Micro Medical, Rochester, UK). PtcO2 and SpO2 were recorded throughout the test as previously described [8] using a Tina CombiM (Radiometer, Bronshoj, Denmark). Lung function was checked to be within the range of normal at baseline and assessed after inhalation of saline (diluent) to obtain the reference for changes during the challenge. Doubling doses of methacholine were inhaled, using the dosimeter method, every 5 min [8], from 50 µg up to a cumulative dose of 800 µg. The test ended when PtcO2 had fallen by 20% or more (PD20PtcO2), the child had respiratory symptoms or the maximal dose of methacholine was reached. The study was approved by the Institutional Review Board of the French learned society for respiratory medicine (Société de Pneumologie de Langue Française) (CEPRO 2013-015) and the children's parents gave informed consent to the study.
Repeated measurements in children were compared using paired the Wilcoxon signed-rank test. Comparisons of lung function indices between groups of children (responsive and nonresponsive) were performed using the Fisher exact test.
27 (13 girls and 14 boys, median (range) age 5.5 (4.2–8.1) years) children completed all measurements during the bronchial challenge. One child pulled off the PtcO2 electrode before the end of the test and was, therefore, excluded. 25 children were referred for chronic cough (started at a median age of 2.7 (0.3–8) years), one for suspicion of wheezing and one for dyspnoea upon exertion.
At baseline, Rintexp was higher than Rintinsp (mean 0.81 versus 0.60 kPa·s·L−1, with a mean difference of −0.21 kPa·s·L−1 (95% CI −0.26– −0.16 kPa·s·L−1); p<0.0001), but within the range of normal for all children [14]. At the time of interruption, expiratory airflow was lower than inspiratory airflow throughout the test (e.g. at baseline: 0.30 and 0.39 L·s−1, respectively; p<0.002). 20 children reached the PD20PtcO2 at a median cumulative dose of methacholine of 100 µg (50–400 µg) (responsive children) without any respiratory symptoms. 14 responsive children had an at least 35% Rintinsp increase (PD35Rintinsp) during the methacholine challenge whereas six responsive children and all the nonresponsive children did not reach PD35Rintinsp (p<0.002). Using Rintexp, there was no association between PD35Rintexp at any time during the test and the presence of BHR (p=1). Therefore, sensitivity and specificity were 70% (95% CI 48–85%) and 100% (95% CI 65–100%), respectively, for Rintinsp, and 50% (95% CI 30–70%) and 57% (95% CI 25–84%), respectively, for Rintexp to detect BHR at or before PD20PtcO2. Taking into account all cases of discordance between Rint and PtcO2 changes (significance of the changes at each test step), the number of discordant Rintexp values (n=19) was higher than that of Rintinsp values (n=11) (table 1). For both Rint measurements, the discordances with PtcO2 changes were equally due to PD35Rint reached before PD20PtcO2 or to a less than 35% Rint increase at PD20PtcO2. In the majority of cases, Rintinsp steadily increased during the bronchial challenge, whereas Rintexp had a more irregular pattern of changes and the final change in Rintexp was smaller than that of Rintinsp in all the study children (table 1). All the children (n=11) whose Rintinsp increased by 35% or more without a concomitant 20% PtcO2 decrease were eventually responsive, whereas three of the nine children with early PD35Rintexp remained nonresponsive throughout the test (three Rintexp false positives). Finally, at PD20PtcO2, Rintinsp and Rintexp would not have diagnosed BHR in six cases and 10 cases, respectively (false negative), representing 12 children, among whom only two had a 5% decrease in SpO2 at the same time.
Changes and discordances during methacholine challenge between interrupter resistance (Rint) and transcutaneous partial pressure of oxygen (PtcO2)
Using Rintinsp changes expressed as percentage of predicted rather than percentage of baseline would have changed the significance of a Rintinsp increase in two out of 81 Rintinsp measurements performed after methacholine inhalation in all study children. These two measurements occurred after the first dose of methacholine in two discordant children (PD35Rintinsp reached before PD20PtcO2) in whom, after the second methacholine inhalation, both changes (% predicted and % baseline) corresponded but remained discordant with that of PD20PtcO2. Therefore, the analysis of the concordance between Rintinsp and PD20PtcO2 changes would not change using percentage predicted or percentage baseline.
If the threshold for Rint were increased by up to 40%, discordance between PtcO2 and Rintinsp would remain the same, whereas discordance with Rintexp would decrease from 19 to 15 cases (still with two false positives). If a 3% decrease in SpO2 were the threshold, 15 out of the 20 responsive children would have reached this threshold at PD20PtcO2 (none before PD20PtcO2), while none of the nonresponsive children would have reached it at any step of the test (p<0.001). Moreover, using PD35Rintinsp or a 3% decrease in SpO2 as a composite criterion for bronchial responsiveness, only one responsive child would not have been diagnosed as responsive at PD20PtcO2 (sensitivity 95%, 95% CI 76–99%) versus six false negatives with PD35Rintinsp or −5% SpO2 criterion.
Our results do not support a universal physiological mechanism to explain discrepancies between Rint and PtcO2 measurements during bronchial challenge in young children. The lack of Rint increase in responsive children could reflect an early ventilation–perfusion mismatch with no central airway obstruction but the better concordance between PtcO2 and Rintinsp over Rintexp remains unexplained. The early reactivity in Rint (before PD20PtcO2) might be due to glottis changes but we failed to demonstrate any specific recurring patterns of changes of airflow at interruption or of difference between Rintinsp and Rintexp explaining the discrepancies recorded.
To challenge the proposed threshold for Rint [1], we switched from a 35% to a 40% increase and the total number of discordances decreased only for Rintexp although they remained higher than that of Rintinsp. However, as a Rint device may measure only Rintexp, the threshold of 40% may be useful to implement. In children with no Rint increase at PD20PtcO2, a 3% decrease in SpO2 better detected BHR than a 5% decrease. The better accuracy of a −3% SpO2 threshold, over a −5% threshold, increases the safety of associating Rint and SpO2 measurements when PtcO2 is not available.
In conclusion, Rintinsp better detects BHR than Rintexp and might better match PD20PtcO2 changes. Until larger studies confirm these first results, it is reasonable to stick to the proposal of favouring measurement of Rintinsp rather than Rintexp during methacholine challenge. Our findings strengthen the recommendation to associate bronchial reactivity outcomes when PtcO2 measurement is not available. Finally, the combination of a 35% Rintinsp increase or a 3% SpO2 decrease might be a useful criterion for detecting BHR with respect to PtcO2 changes.
Acknowledgments
We are grateful to Michèle Boulé, Houda Guillo, Marc Koskas, Marie-Claude La Rocca, Lucia Maingot and Noria Medjahdi for their help in recruiting the children, and to Claire Goaguen, Pascal Jacquemart, Valérie Le Bail, Isabelle Schmit and Françoise Vallée (APHP, hôpital Armand Trousseau, Paris, France) for technical assistance. We thank Corinne Alberti (Robert Debré Hospital, Paris, France) for her help with the statistical analysis and Evan Knight for his help in preparing this manuscript.
Footnotes
Conflict of interest: None declared.
- Received May 11, 2015.
- Accepted October 11, 2015.
- Copyright ©ERS 2015
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.